8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Jasper Therapeutics filed an 8-K with the SEC on Nov 4 (a notice of a material company event).
Directly affected
- JSPR Jasper Therapeutics-15.0% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Jasper Therapeutics belongs to, so it often moves with news about it.
- AMGN Amgen+13.5% 30d
Amgen is a peer of Jasper Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+13.4% 30d
Gilead Sciences is a peer of Jasper Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+25.4% 30d
Moderna is a peer of Jasper Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-16.8% 15d
argenx SE is a peer of Jasper Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Jasper Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| JSPR | +8.44% | +8.37% | base | after close | after close | after close | after close |
| XLV | -2.31% | +0.48% | base | after close | after close | after close | after close |
| AMGN | -2.03% | +1.07% | base | after close | after close | after close | after close |
| GILD | -4.93% | +2.07% | base | after close | after close | after close | after close |
| MRNA | -6.29% | -2.97% | base | after close | after close | after close | after close |
| ARGX | -1.09% | -0.93% | base | after close | after close | after close | after close |
| RVMD | -2.84% | -1.45% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-04 AccNo: 0001213900-26-115751 Size: 263 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclos…
Source: sec-edgar
How far Jasper Therapeutics (JSPR) has moved since 4 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| Amgen (AMGN) | three days earlier | +1.07% | final price |
| Amgen (AMGN) | five days earlier | -2.03% | final price |
| Argenx Se (ARGX) | three days earlier | -0.93% | final price |
| Argenx Se (ARGX) | five days earlier | -1.09% | final price |
| Gilead Sciences (GILD) | three days earlier | +2.07% | final price |
| Gilead Sciences (GILD) | five days earlier | -4.93% | final price |
| Jasper Therapeutics (JSPR) | three days earlier | +8.37% | final price |
| Jasper Therapeutics (JSPR) | five days earlier | +8.44% | final price |
| Moderna (MRNA) | three days earlier | -2.97% | final price |
| Moderna (MRNA) | five days earlier | -6.29% | final price |
| Revolution Medicines (RVMD) | three days earlier | -1.45% | final price |
| Revolution Medicines (RVMD) | five days earlier | -2.84% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | +0.48% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -2.31% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 43 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 70 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 84 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 86 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 61 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 68 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)”
Companies tied to this story
- JSPR Jasper Therapeutics
For “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer),” Jasper Therapeutics (JSPR) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> JSPR
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 4 Nov 2026 story “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer).” Reason on file: Health Care Select Sector SPDR holds the health sector that Jasper Therapeutics belongs to, so it often moves with news about it
- AMGN Amgen
Amgen (AMGN) is linked, with no stored direction, medium confidence in the 4 Nov 2026 story “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer).” Reason on file: Amgen is a peer of Jasper Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news
- GILD Gilead Sciences
In “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer),” Gilead Sciences (GILD) is linked, with no stored direction, medium confidence. Reason on file: Gilead Sciences is a peer of Jasper Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news
- MRNA Moderna
In “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer),” Moderna (MRNA) is linked, with no stored direction, medium confidence. Reason on file: Moderna is a peer of Jasper Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news
- ARGX Argenx Se
Argenx Se (ARGX) is linked, with no stored direction, medium confidence in the 4 Nov 2026 story “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer).” Reason on file: argenx SE is a peer of Jasper Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news
- RVMD Revolution Medicines
In “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer),” Revolution Medicines (RVMD) is linked, with no stored direction, medium confidence. Reason on file: Revolution Medicines is a peer of Jasper Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news
How “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)” reaches Jasper Therapeutics (JSPR)
On 4 Nov 2026, “8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)” is the story that connects Jasper Therapeutics (JSPR) to this story.
For Jasper Therapeutics (JSPR), the reason on file says SEC 8-K filing -> direct issuer disclosure -> JSPR
Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR holds the health sector that Jasper Therapeutics belongs to, so it often moves with news about it
Dates in the story, and the Jasper Therapeutics (JSPR) price range
AMGN traded between 400.20 and 475.42 across 20 sessions. The latest close on file is 460.78. JSPR traded between 0.46 and 0.59 across 20 sessions. The latest close on file is 0.48.
What the saved facts support for Jasper Therapeutics (JSPR)
46 out of 100
“8-K - Jasper Therapeutics, Inc. (0001788028) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.